¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"anti"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • antigen-antibody interaction
    Ç׿øÇ×ü»óÈ£ÀÛ¿ë
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • antigen-binding site
    Ç׿ø°áÇÕºÎÀ§
  • antigen-combining site
    Ç׿ø°áÇÕºÎÀ§
  • antigen-presenting cell
    Ç׿øÁ¦½Ã¼¼Æ÷
  • antigen-reactive cell
    Ç׿ø¹ÝÀÀ¼¼Æ÷
  • antigen-recognition site
    Ç׿øÀÎÁöºÎÀ§
  • antigen-recognizing cell
    Ç׿øÀÎÁö¼¼Æ÷
  • antigenemia
    Ç׿øÇ÷Áõ
  • antigenic deletion
    Ç׿ø°á¼Õ
  • antigenic determinant
    Ç׿ø°áÁ¤ÀÎÀÚ
  • antigenic diversion
    Ç׿øÀüȯ
  • antigenic drift
    Ç׿øº¯ÀÌ
  • antigenic profile
    Ç׿øÇÁ·ÎÇÊ
  • antigenic reversion
    Ç׿øº¹±Í
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • antigenic drift
    Ç׿ø¼ÒÆøº¯ÀÌ
  • antigenic profile
    Ç׿øÇÁ·ÎÇÊ
  • antigenic reversion
    Ç׿øº¹±Í
  • antigenic shift
    Ç׿øº¯À§
  • antigenic specificity
    Ç׿øÆ¯À̼º
  • antigenic stimulation
    Ç׿øÀÚ±Ø
  • antigenic transformation
    Ç׿øº¯È¯
  • antigenicity
    Ç׿ø¼º
  • antigenotherapy
    Ç׿ø¿ä¹ý
  • antiglobulin reaction
    Çױ۷κҸ°¹ÝÀÀ
  • antiglobulin reagent
    Çױ۷κи°½Ã¾à
  • antiglobulin test
    Çױ۷κҸ°°Ë»ç
  • antigravity suit
    Ç×Á߷º¹
  • antihelical fold
    ±Í¸ÂµÑ·¹ÁÖ¸§
  • antihemicranin
    ÆíµÎÅë¾à
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • antibody, cross-reacting
    ±³Â÷¹ÝÀÀÇ×ü
  • antibody, cytolytic
    ¼¼Æ÷¿ëÇØÇ×ü
  • antibody, cytophilic
    ¼¼Æ÷ģȭ¼ºÇ×ü
  • antibody, cytotoxic
    ¼¼Æ÷µ¶¼ºÇ×ü
  • antibody, cytotropic
    ¼¼Æ÷ģȭ¼ºÇ×ü
  • antibody, enzyme-labelled
    È¿¼ÒÇ¥ÁöÇ×ü
  • antibody, ferritin-labelled
    Æä¸®Æ¾Ç¥ÁöÇ×ü
  • antibody, fluorescein-labelled
    Çü±¤Ç¥ÁöÇ×ü
  • antibody, hemolytic
    ¿ëÇ÷¼ºÇ×ü
  • antibody, heterocytotropic
    ÀÌÁ¾¼¼Æ÷ ģȭ¼ºÇ×ü
  • antibody, heterophile
    ÀÌÁ¾Ç׿ø ģȭ¼ºÇ×ü
  • antibody, homocytotropic
    µ¿Á¾¼¼Æ÷ģȭ¼ºÇ×ü
  • antibody, hybrid
    ÇÏÀ̺긮µåÇ×ü
  • antibody, immobilizing
    ¿îµ¿¾ïÁ¦Ç×ü
  • antibody, maternal
    ¸ðüÇ×ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • antibody, cross-reacting
    ±³Â÷¹ÝÀÀÇ×ü
  • antibody, cytolytic
    ¼¼Æ÷¿ëÇØÇ×ü
  • antibody, cytophilic
    ¼¼Æ÷ģȭ¼ºÇ×ü
  • antibody, cytotoxic
    ¼¼Æ÷µ¶¼ºÇ×ü
  • antibody, cytotropic
    ¼¼Æ÷ģȭ¼ºÇ×ü
  • antibody, enzyme-labelled
    È¿¼ÒÇ¥ÁöÇ×ü
  • antibody, ferritin-labelled
    Æä¸®Æ¾Ç¥ÁöÇ×ü
  • antibody, fluorescein-labelled
    Çü±¤Ç¥ÁöÇ×ü
  • antibody, hemolytic
    ¿ëÇ÷¼ºÇ×ü
  • antibody, heterocytotropic
    ÀÌÁ¾¼¼Æ÷ ģȭ¼ºÇ×ü
  • antibody, heterophile
    ÀÌÁ¾Ç׿ø ģȭ¼ºÇ×ü
  • antibody, homocytotropic
    µ¿Á¾¼¼Æ÷ģȭ¼ºÇ×ü
  • antibody, hybrid
    ÇÏÀ̺긮µåÇ×ü
  • antibody, immobilizing
    ¿îµ¿¾ïÁ¦Ç×ü
  • antibody, maternal
    ¸ðüÇ×ü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • antiviral agent
    Ç×(ù÷) ¹ÙÀÌ·¯½ºÁ¦(ð¥)
  • antiviral protein
    Ç×(ù÷) ¹ÙÀÌ·¯½º ´Ü¹éÁú(Ó±ÛÜòõ)
  • antivitamin
    Ç×(ù÷) ºñŸ¹Î
  • antixerophthalmic factor
    Ç׾ȱ¸ °ÇÁ¶Áõ ÀÎÀÚ(ù÷äÑϹËëðÏñøì×í­)
  • antizyme
    ¾ÈƼÀÚÀÓ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
DMARD disease-modifying anti-rheumatic drug
GPAIS guinea pig anti-insulin serum
HAMA Hamilton anxiety [scale]; human anti-murine antibody
HAPA hemagglutinating anti-penicillin antibody
HoaRhLG horse anti-rhesus lymphocyte globulin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
HSV Anti-herpes simplex virus
AHA Anti-histone antibodies
HCMV Anti-human cytomegalovirus
HIV Anti-human immunodeficiency virus
HIV-1 Anti-human immunodeficiency virus type 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • T46.8
    Antivaricose drugs, including sclerosing agents
    °æÈ­¼º ¾à¹° Æ÷ÇÔÇÑ Ç×Á¤¸Æ·ù¼º ¾à¹°
  • Y41.5
    Antiviral drugs
    Ç×¹ÙÀÌ·¯½º ¾à¹°
  • T37.5
    Antiviral drugs
    Ç×¹ÙÀÌ·¯½º¼º ¾à¹°
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antimalarial drug
    Ç׸»¶ó¸®¾ÆÁ¦
  • antimaniacal
    Ç×Á¶º´ÀÇ, Ç×Á¶º´ ¾à
  • antimesenteric
    Àå°£¸· ´ëÃøÀÇ
  • antimicobial assay
    Ç×±ÕÁ¦ ÃøÁ¤
  • antimicrobial action
    Ç×±Õ ÀÛ¿ë
  • antimicrobial chemotherapy
    Çâ±Õ È­ÇÐ ¿ä¹ý
  • antimicrobial level
    Ç×±ÕÁ¦Ä¡
  • antimicrobial susceptibility
    Ç×±ÕÁ¦ °¨¼ö¼º, Ç×±Õ °¨¼ö¼º
  • antimicrobial therapy
    Ç×±Õ ¿ä¹ý
  • antimicrobiotic
    »ì±ÕÁ¦
  • antimold
    Ç×°õÆÎÀÌ
  • antimonate
    ¾ÈƼ¸ó»ê¿°
  • antimonial
    ¾ÈƼ¸óÁ¦
  • antimony
    ¾ÈƼ¸ó
    Ǫ¸¥ ±¤ÅÃÀÌ ÀÖ°í °ß°íÇÑ °áÁ¤¼º ±Ý¼Ó ¿ø¼Ò. ¿ø¼Ò ±âÈ£ Sb, ¿øÀÚ ¹øÈ£ 51, ¿øÀÚ·® 121.75. ¿©·¯ ¿°ÀÌ ÀÇÇпëÀ¸·Î »ç¿ëµÇ±âµµ Çϰí, µ¶¹°ÀÌ µÇ±âµµ ÇÑ´Ù.
  • antimuscarinic
    Ç×¹«½ºÄ«¸° ¾à, Ç×¹«½ºÄ«¸°¼º ¾à, Ç×¹«½ºÄ«¸°¼ºÀÇ
    ¹«½ºÄ«¸°ÀÇ µ¶ÀÛ¿ë¿¡ ±æÇ×ÇÏ¿© È¿°úÀûÀÎ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
antibody excess In a precipitation test, the presence of antibody in an amount greater than that required to combine with all of the antigen present.
(05 Mar 2000)
antibody induced lysis <haematology> The term is imprecise and should not be used since there is confusion as to which mechanism is involved, i.e. Natural killing or complement lysis.
See: complement lysis, natural killer cells.
(09 Feb 1998)
antibody producing cell <immunology> A lymphocyte of the B series synthesising and releasing immunoglobulin. Equivalent to plasmacyte and plasma cell.
(18 Nov 1997)
antibody specificity The property of antibodies which enables them to react with some antigenic determinants and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
(12 Dec 1998)
antibody technology <molecular biology> Techniques for the synthesis of polyclonal and monoclonal antibodies for use in research, diagnostics and therapeutics.
(09 Feb 1998)
antibody-coated bacteria test, urinary Fluorescent antibody technique for visualizing antibody-bacteria complexes in urine. The presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively.
(12 Dec 1998)
antibody-dependent cell cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitised effector cells. The identity of the target cell varies, but it must possess surface IgG whose fc portion is intact. The effector cell is a "killer" cell possessing fc receptors. It may be a lymphocyte lacking conventional b- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent.
(12 Dec 1998)
antibody-dependent enhancement Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by fc receptors (receptors, fc) or by complement receptors (receptors, complement). Either the virus is complexed with antiviral IgG and binds to fc receptors, or virus is coated with antiviral IgM and binds to complement receptors.
(12 Dec 1998)
antibody-forming cell <immunology> B-cells (plasma cells) that are dedicated to producing secreted antibodies.
(09 Feb 1998)
antibody-producing cells Cells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. Various cell subpopulations, often B-lymphocytes, can be defined, based on the different classes of immunoglobulins that they synthesise.
(12 Dec 1998)
antibrachial <anatomy> Of or pertaining to the antibrachium, or forearm.
Source: Websters Dictionary
(01 Mar 1998)
antibrachium <anatomy> That part of the fore limb between the brachium and the carpus; the forearm.
Source: Websters Dictionary
(01 Mar 1998)
antibromic 1. Deodorizing.
2. A deodoriser.
Origin: anti-+ G. Bromos, smell
(05 Mar 2000)
antic 1. Old; antique.
<zoology> "Lords of antic fame."
2. Odd; fantastic; fanciful; grotesque; ludicrous. "The antic postures of a merry-andrew." (Addison) "The Saxons . . . Worshiped many idols, barbarous in name, some monstrous, all antic for shape." (Fuller)
Origin: The same word as antique; cf. It. Antico ancient. See Antique.
Source: Websters Dictionary
(01 Mar 1998)
anticalculous <medicine> Tending to prevent the formation of urinary calculi, or to destroy them when formed.
An antilithic medicine.
Source: Websters Dictionary
(01 Mar 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 10
  • Antibody-Coated Bacteria Test, Urinary - »õâ Fluorescent antibody technique for visualizing antibody-bacteria complexes in urine. The presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively.
    Synonyms : Antibody Coated Bacteria Test, Urinary, Urinary Antibody-Coated Bacteria Test, Urinary Antibody Coated Bacteria Test
  • Antibody-Dependent Cell Cytotoxicity - »õâ The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent.
    Synonyms : Cell Cytoxicity, Antibody-Dependent, Antibody Dependent Cell Cytotoxicity, Antibody-Dependent Cell Cytotoxicities, Antibody-Dependent Cell Cytoxicities, Antibody-Dependent Cell Cytoxicity, Cell Cytotoxicities, Antibody-Dependent
  • Antibody-Dependent Enhancement - »õâ Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by Fc receptors (RECEPTORS, FC) or by complement receptors (RECEPTORS, COMPLEMENT). Either the virus is complexed with antiviral IMMUNOGLOBULIN G and binds to Fc receptors, or virus is coated with antiviral IMMUNOGLOBULIN M and binds to complement receptors.
    Synonyms : Antibody Dependent Enhancement, Antibody-Dependent Enhancements, Enhancement, Antibody-Dependent
  • Antibody-Producing Cells - »õâ Cells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. Various cell subpopulations, often B-lymphocytes, can be defined, based on the different classes of immunoglobulins that they synthesize.
    Synonyms : Antibody Producing Cells, Antibody Secreting Cells, Antibody-Producing Cell, Antibody-Secreting Cell, Cell, Antibody-Producing, Cell, Antibody-Secreting, Cell, Immunoglobulin-Producing, Cell, Immunoglobulin-Secreting, Cells, Antibody-Producing
  • Anticarcinogenic Agents - »õâ Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. They differ from antineoplastic agents in that they prevent neoplasms from forming. The anticarcinogenic substances can be divided into three categories. The first consists of compounds that prevent the formation of carcinogens from precursor substances. The second group consists of "blocking agents" which inhibit carcinogenesis by preventing carcinogenic agents from reaching or reacting with critical target sites in the tissues. The third group is the "suppressor agents" which act by suppression of expression of neoplasia in cells previously exposed to carcinogens that would otherwise cause neoplasms.
    Synonyms : Anti-Carcinogenic Agents, Anti-Carcinogenic Drugs, Anticarcinogenic Drugs, Anticarcinogens, Agents, Anti-Carcinogenic, Agents, Anticarcinogenic, Anti Carcinogenic Agents, Anti Carcinogenic Drugs, Drugs, Anti-Carcinogenic, Drugs, Anticarcinogenic
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
antiepileptic anticonvulsant: a drug used to treat or prevent convulsions (as in epilepsy)
Ãâó: wordnet.princeton.edu/perl/webwn
antiflatulent any agent that reduces intestinal gas
Ãâó: wordnet.princeton.edu/perl/webwn
antimonic relating to or derived from antimony; "antimonious oxide"
Ãâó: wordnet.princeton.edu/perl/webwn
antimonious antimonic: relating to or derived from antimony; "antimonious oxide"
Ãâó: wordnet.princeton.edu/perl/webwn
antimony potassium tartrate tartar emetic: a poisonous colorless salt used as a mordant and in medicine
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • antinatalism
    Àα¸ Áõ°¡ ¾ïÁ¦ ÁÖÀÇ
  • antinatalist
    Àα¸ ¾ïÁ¦ Á¸ÀÚ;Àα¸ ¾ïÁ¦·ÐÀÇ
  • antinational
    ¹Ý±¹°¡ÀûÀÎ;±¹°¡ÁÖÀÇ¿¡ ¹Ý´ëÇÏ´Â
  • antiNegro
    ¹ÝÈæÀÎÀÇ
  • antineoplastic
    Ç× Á¾¾ç¼ºÀÇ;Ç×Á¾¾ç¾à
  • antineuralgic
    Ç× ½Å°æÅëÀÇ;½Å°æÅë¾à
  • antineutrino
    ¹ÝÁß¼º¹ÌÀÚ
  • antineutron
    ¹ÝÁß¼ºÀÚ
  • antinoise
    ¼ÒÀ½ ¹æÁöÀÇ
  • antinomian
    µµ´ö·ü Æó±â·ÐÀÚÀÇ;µµ´ö·ü Æó±â·ÐÀÚ
  • antinomianism
    µµ´ö·üÆó±â;½Å¾Ó Áö»ó·Ð
  • antinomy
    ¸ð¼ø;´çÂø;ÀÌÀ²¹è¹Ý
  • antinovel
    ¹Ý¼Ò¼³(ºñÀüÅëÀûÀÎ ¼ö¹ýÀÇ)
  • antinuclear
    ¹ÝÇÙÀÇ;ÇÙ¹«±â¹Ý´ëÀÇ
  • antinucleon
    ¹ÝÇÙÀÚ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 10
anti a drug used to treat or prevent convulsions (as in epilepsy)
anti a drug used to treat or prevent convulsions (as in epilepsy)
anti activity indicative of belief in the superiority of men over women
anti someone who does not believe in the social or economic or political equality of men and women
anti relating to antiferromagnetism
anti magnetic field creates parallel but opposing spins
anti capable of preventing conception or impregnation
anti any agent that reduces intestinal gas
anti (nautical) used of e.g. coatings to protect against accumulation of barnacles etc on underwater surfaces
anti a liquid added to the water in a cooling system to lower its freezing point
anti any agent that destroys or prevents the growth of fungi
anti capable of destroying fungi
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 10
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á